La evolución de las patentes sobre medicamentos en los países desarrollados

La evolución de las patentes sobre medicamentos en los países desarrollados PDF Author: Félix Lobo
Publisher:
ISBN:
Category :
Languages : es
Pages : 46

Get Book Here

Book Description

La evolución de las patentes sobre medicamentos en los países desarrollados

La evolución de las patentes sobre medicamentos en los países desarrollados PDF Author: Félix Lobo
Publisher:
ISBN:
Category :
Languages : es
Pages : 46

Get Book Here

Book Description


Medicamentos esenciales y propiedad intelectual

Medicamentos esenciales y propiedad intelectual PDF Author: Luis Edgar Parra Salas
Publisher: Editorial Pontificia Universidad Javeriana
ISBN: 9587167201
Category : Medical
Languages : es
Pages : 235

Get Book Here

Book Description
La propiedad intelectual es cada vez más importante en el mundo globalizado, que ha estructurado un nuevo orden en el que los Estados pierden soberanía para poder formular políticas públicas que protejan a sus ciudadanos A partir de un enfoque crítico dual (compuesto por el análisis político, económico e internacional y los estudios sobre salud pública y administración de salud) esta investigación intenta explicar las causas por las cuales las relaciones de poder global, vigentes en el mundo actual, han generado una barrera estructural para que los países en desarrollo accedan a medicamentos esenciales y a la tecnología biomédica El presente libro busca facilitar la comprensión de problemas contemporáneos de la salud global relacionados con la transferencia internacional de riesgos para la salud Además, está especialmente dirigido a los responsables del análisis y la formulación de las políticas públicas comerciales y de salud, y a todos aquellos actores que intervienen en la prestación de los servicios asistenciales, pues la dinámica global afecta su cotidianidad, incluso la nuestra, sin que muchas veces seamos conscientes de ello

Patentes farmacéuticas y países en desarrollo

Patentes farmacéuticas y países en desarrollo PDF Author: Marta Ortega Gómez
Publisher:
ISBN: 9788415150251
Category : Drugs
Languages : es
Pages : 249

Get Book Here

Book Description


U.S. foreign policy and intellectual property rights in Latin America

U.S. foreign policy and intellectual property rights in Latin America PDF Author:
Publisher: Hoover Press
ISBN: 9780817958237
Category : America
Languages : en
Pages : 44

Get Book Here

Book Description


Journal of World Trade

Journal of World Trade PDF Author:
Publisher:
ISBN:
Category : Foreign trade regulation
Languages : en
Pages : 422

Get Book Here

Book Description


Strengthening Protection of Intellectual Property in Developing Countries

Strengthening Protection of Intellectual Property in Developing Countries PDF Author: Wolfgang E. Siebeck
Publisher:
ISBN:
Category : Intellectual property
Languages : en
Pages : 152

Get Book Here

Book Description
An overview of intellectual property systems; Guidance from economic theory; Survey of empirical studies; The developing countru case for and against intellectual property protection.

Pharmaceutical Innovation and Access to Medicines

Pharmaceutical Innovation and Access to Medicines PDF Author: OECD
Publisher: Org. for Economic Cooperation & Development
ISBN: 9789264307384
Category : Drug accessibility
Languages : en
Pages : 0

Get Book Here

Book Description
This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.

Patent Protection for Second Medical Uses

Patent Protection for Second Medical Uses PDF Author: Jochen Bühling
Publisher: Kluwer Law International B.V.
ISBN: 9041182780
Category : Law
Languages : en
Pages : 531

Get Book Here

Book Description
When a party develops a ‘second medical use’ for a known substance or compound, special issues of patentability arise. Jurisdictions around the world vary significantly in their treatment of such claims. This detailed country-by-country analysis provides clarity, insight, and guidance on the legal issues and practical implications of second medical use claims in nineteen jurisdictions worldwide as well as the European Union. The authors of the country chapters have been carefully selected based on a broad basis of experience and in-depth knowledge about medical patents in their respective jurisdictions. Each chapter considers such issues and topics as the following: • availability of protection; • validity of claims; • scope of protection; • enforcement; and • infringement. A general chapter about the practice of the European Patent Office (EPO) addresses in particular the latest changes in the format of second medical use claims from the “Swiss-type claims” to the “EPC 2000 claims”. Specific issues and national peculiarities which deviate from the EPO practice are explained in the various national European chapters, while chapters on jurisdictions outside Europe cover both prosecution and enforcement of patents with second medical use claims. As a comparative law study and a collection of contributions from around the world on an important and controversial field, this book will prove of tremendous practical interest for the industry involved and for the public. Applicants for pharmaceutical patents, third parties, and interested legal practitioners will benefit greatly from its thorough comparative analysis and guidance. This book is the second volume in the AIPPI Law Series which has been established together with the International Association for the Protection of Intellectual Property (AIPPI).

Recollections of My Life

Recollections of My Life PDF Author: Santiago Ramón y Cajal
Publisher:
ISBN:
Category : Nervous system
Languages : en
Pages : 702

Get Book Here

Book Description


Making Medicines Affordable

Making Medicines Affordable PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

Get Book Here

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.